XRCC5 and neoplasm: Finally, although we developed a Ku80 K568cr-specific antibody, we have not yet screened human tumor samples (TMA) and normal tissues using this antibody to evaluate endogenous levels of Ku80 crtononylation and correlate with patient survival or outcome.